4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone has been researched along with apigenin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Eibl, G; Hines, OJ; King, J; Pandol, S; Pham, H; Reber, HA; Takahashi, H | 1 |
1 other study(ies) available for 4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone and apigenin
Article | Year |
---|---|
Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells.
Topics: Antineoplastic Agents; Apigenin; Carcinogens; Cell Line, Tumor; Cell Movement; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Humans; Nitrosamines; Pancreatic Neoplasms; Propranolol; Receptors, Adrenergic, beta; Signal Transduction | 2012 |